High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.

Fifty-one lepromatous leprosy patients, all of whom had relapsed after previous dapsone (DDS) monotherapy, were treated between 1990 and 1991 with 600 mg of rifampin (RMP) plus 400 mg of ofloxacin (OFLO) daily for 4 weeks, and the great majority of the patients were followed up at least once a year...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Ji, B, Jamet, P, Sow, S, Perani, E G, Traore, I, Grosset, J H
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1997
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164043/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9303392/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.9.1953
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!